Multicellular living organisms and unmodified parts thereof and – Method of introducing a polynucleotide molecule into or... – The polynucleotide alters fat – fatty oil – ester-type wax – or...
Patent
1996-04-03
1999-05-25
Ketter, James
Multicellular living organisms and unmodified parts thereof and
Method of introducing a polynucleotide molecule into or...
The polynucleotide alters fat, fatty oil, ester-type wax, or...
800250, 800255, 536 231, 536 245, 4353201, 435411, 435414, A01H 104
Patent
active
059070846
DESCRIPTION:
BRIEF SUMMARY
The present invention relates to cells having a genetically engineered reduced susceptibility to viruses, processes for obtaining such cells, and genetic material capable of generating such reduced susceptibility. In a preferred embodiment the cells are plant cells.
Numerous attempts have been made to engineer viral resistance into plants by inserting DNA-containing vectors into acceptor plant tissue, which DNA is capable of encoding viral proteins in the thus transformed plant. The viral protein may confer resistance to an invading virus comprising a viral protein substantially the same as that encoded by the introduced DNA. Other attempts at engineering virus resistance in plants use anti-sense RNA which relies on the introduction of DNA encoding an RNA strand which is complementary to the RNA of an invading virus and thus interferes with the replication thereof. Plants displaying a broad degree of reduced susceptibility, i.e. to more than one viral type, or a greater degree of reduced susceptibility to a particular virus type, are highly desirable.
Resistance in plants to multiple virus types may be obtained by transforming plant tissue with DNA constructs made up of individual blocks of genetic elements, each element consisting essentially of three components: terminators and typically suffer from genetic instability.
The present invention provides inter alia, novel nucleotide sequences which can be used in the production of eukaryotic cells--particularly plant cells--which exhibit an improved resistance or tolerance to viruses. Such improvements surprisingly correlate primarily with the levels of the RNA and sub-sequences thereof encoded by the nucleotide sequence of the invention, rather than the levels of the translation products of such RNA. Indeed, improved resistance or tolerance may be obtained by transcription of the present inventive nucleotide sequences in eukaryotic cells, substantially in the absence of the translation of such transcription products.
According to the present invention there is provided a nucleotide sequence (nucleotide sequence according to the invention) comprising a transcriptional regulatory sequence and a sequence contiguous therewith and under the transcriptional control thereof, which contiguous sequence encodes an RNA which consists of a plurality of sub-sequences, characterized in that at least two of the sub-sequences have the sequences of viral RNAs and the RNA contains at least one translational stop codon located upstream of the 3' terminal sub-sequence.
Each of the sub-sequences may be responsible for conferring a reduced susceptibility to a virus in plant cells or for conferring an enhanced reduced susceptibility to a single virus type in plant cells. Such sub-sequences need not necessarily be capable of encoding protein, and it is preferred that at least one of them is incapable of encoding protein as a consequence of the RNA lacking a translational start codon at the 5' thereof and/or the contiguous sequence encoding a second sub-sequence down stream from a first sequence, the second sequence defining a translational reading frame which is out of phase with that defined by the first sub-sequence.
The said nucleotide sequence may encode an RNA having any number of sub-sequences. It is preferred that the number of sub-sequences is between 2 and 7 (inclusive) and still more preferred that the number is likewise between 2 and 4.
At least one of the sub-sequences may be in an anti-sense configuration with respect to virus RNA. The contiguous sequence may encode mRNA.
It is preferred that at least one of the sub-sequences is a cistron. By "cistron" is meant an RNA which contains a translation open reading frame, i.e. one that comprises a translation start codon, protein encoding sequence and a translation stop codon.
It is preferred that the RNA encoded by the contiguous sequence comprises at least one ribozyme (or other cleavage site) between two of the sub-sequences so that the RNA can be cleaved into regions comprising the said sub-sequences, or even into the s
REFERENCES:
patent: 5316930 (1994-05-01), Loesch-Fries et al.
patent: 5503999 (1996-04-01), Jilka et al.
patent: 5589612 (1996-12-01), Jilka et al.
Lawson et al. Bio/Technology, vol. 8, pp. 127-134, 1990.
Yie et al. Molecular Plant-Microbe Interactions, vol. 5 (6), pp. 460-465, 1992.
Lamb et al. Journal of General Virology, vol. 71, pp. 2257-2264, 1990.
Tabler et al. Gene, vol. 108, pp. 175-183, 1991.
Milligan et al. Journal of Medicinal Chemistry, vol. 36 (14), pp. 1923-1937, Jul. 9, 1993.
Hoxie Thomas
Ketter James
Meigs J. Timothy
Novartis Finance Corporation
Yucel Irem
LandOfFree
Virus resistant or tolerant cells does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Virus resistant or tolerant cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Virus resistant or tolerant cells will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-402032